BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  NeurogesX, Inc. Expands Access to State-of-the-art HPV Screening in China Through Co-marketing Agreement With FDA

  March 8, 2012

   · 

  5 min read
• Deals

  Osprey Medical Inc. Launches A$20 Million IPO

  March 8, 2012

   · 

  5 min read
• Business

  NeurogesX, Inc. Cuts 57% of Staff, Shifts R&D Focus as FDA Rejects HIV Pain Patch

  March 8, 2012

   · 

  12 min read
• Lone Star Bio

  Bellicum Pharmaceuticals, Inc. Closes $20 Million Series B Financing

  March 8, 2012

   · 

  3 min read
• Drug Development

  Johnson & Johnson’s Zytiga Scores Big Win, Hurts Dendreon Corporation, Helps Medivation, Inc.

  March 8, 2012

   · 

  1 min read
• Drug Development

  Gilead Sciences, Inc.’s Four-in-One AIDS Pill is Effective in Study

  March 8, 2012

   · 

  7 min read
• BioMidwest

  National Center for Genome Resources Hosts Symposium on Functional Genomics

  March 8, 2012

   · 

  1 min read
• Business

  Affymax, Inc. Announces Yearend 2011 Financial Results Teleconference and Webcast

  March 8, 2012

   · 

  1 min read
• Drug Development

  Promedior Receives U.S. Orphan Drug Designation for PRM-151 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

  March 8, 2012

   · 

  1 min read
• Business

  Verastem, Inc. Announces Timing for Year-End 2011 Financial Results, Webcast and Conference Call

  March 8, 2012

   · 

  1 min read